Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Pembrolizumab in metastatic non-small cell lung cancer: NCT07809256 Clinical Landscape Report 2026
9 min read
Pembrolizumab in metastatic non-small cell lung cancer: NCT07809256 Clinical Landscape Report 2026
11 September 2026
NCT07809256 clinical landscape for metastatic non-small cell lung cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white…
Read →
Universal STAR-T Cell(BriSTAR Immunotech) in Myasthenia Gravis: NCT07714798 Clinical Landscape Report 2026
9 min read
Universal STAR-T Cell(BriSTAR Immunotech) in Myasthenia Gravis: NCT07714798 Clinical Landscape Report 2026
11 September 2026
NCT07714798 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Dexamethasone Sodium Phosphate in Relapse multiple myeloma: NCT07811986 Clinical Landscape Report 2026
9 min read
Dexamethasone Sodium Phosphate in Relapse multiple myeloma: NCT07811986 Clinical Landscape Report 2026
11 September 2026
NCT07811986 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Zugocaptagene Geleucel in Neuromyelitis Optica: NCT07804004 Clinical Landscape Report 2026
9 min read
Zugocaptagene Geleucel in Neuromyelitis Optica: NCT07804004 Clinical Landscape Report 2026
11 September 2026
NCT07804004 clinical landscape for Neuromyelitis Optica: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Polyethylene glycol 4000 in Inflammatory Bowel Diseases: NCT07786363 Clinical Landscape Report 2026
9 min read
Polyethylene glycol 4000 in Inflammatory Bowel Diseases: NCT07786363 Clinical Landscape Report 2026
11 September 2026
NCT07786363 clinical landscape for Inflammatory Bowel Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Temozolomide in Melanoma, Cutaneous Malignant: NCT07807878 Clinical Landscape Report 2026
9 min read
Temozolomide in Melanoma, Cutaneous Malignant: NCT07807878 Clinical Landscape Report 2026
11 September 2026
NCT07807878 clinical landscape for Melanoma, Cutaneous Malignant: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Mazdutide in Metabolic Dysfunction Associated Steatohepatitis: NCT07718126 Clinical Landscape Report 2026
9 min read
Mazdutide in Metabolic Dysfunction Associated Steatohepatitis: NCT07718126 Clinical Landscape Report 2026
11 September 2026
NCT07718126 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
Read →
[18F]FAPI-74 in Fibrosis, Liver: NCT07705074 Clinical Landscape Report 2026
9 min read
[18F]FAPI-74 in Fibrosis, Liver: NCT07705074 Clinical Landscape Report 2026
11 September 2026
NCT07705074 clinical landscape for Fibrosis, Liver: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Bevacizumab in Advanced Hepatocellular Carcinoma: NCT07813572 Clinical Landscape Report 2026
9 min read
Bevacizumab in Advanced Hepatocellular Carcinoma: NCT07813572 Clinical Landscape Report 2026
11 September 2026
NCT07813572 clinical landscape for Advanced Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
Read →
GDC-3280 in Idiopathic Pulmonary Fibrosis: NCT07719023 Clinical Landscape Report 2026
9 min read
GDC-3280 in Idiopathic Pulmonary Fibrosis: NCT07719023 Clinical Landscape Report 2026
11 September 2026
NCT07719023 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Recombinant human coagulation factor VIII-Fc fusion protein (Gensciences) in Hemophilia A: NCT07684898 Clinical Landscape Report 2026
9 min read
Recombinant human coagulation factor VIII-Fc fusion protein (Gensciences) in Hemophilia A: NCT07684898 Clinical Landscape Report 2026
11 September 2026
NCT07684898 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Tislelizumab in Locally Advanced Esophageal Squamous Cell Carcinoma: NCT07811752 Clinical Landscape Report 2026
9 min read
Tislelizumab in Locally Advanced Esophageal Squamous Cell Carcinoma: NCT07811752 Clinical Landscape Report 2026
11 September 2026
NCT07811752 clinical landscape for Locally Advanced Esophageal Squamous Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and dev…
Read →